IL1B and neoplasm: Our findings show that the expression of inflammasomes and the proinflammatory cytokine, IL-1β, in tumour cells is significantly correlated with better survival in NPC patients (Fig 1), suggesting a role of tumour inflammasomes in tumour suppression.